Prenatal Choline May Boost Children’s IQ, Study Finds

A randomized trial found that prenatal phosphatidylcholine supplementation improved IQ scores and reduced social withdrawal in children through age four, though it did not affect attention problems. The findings suggest early nutritional interventions may influence neurodevelopment. Other research highlighted links between head shape, amyloid onset, and aspirin’s potential role in dementia prevention.

A 2026 randomized trial published in the American Journal of Obstetrics and Gynecology found that prenatal supplementation with phosphatidylcholine improved cognitive outcomes in children through age four, with measurable increases in IQ scores and reductions in social withdrawal behaviors. The study did not find significant changes in attention problems, suggesting a selective impact on certain neurodevelopmental domains. While the exact dosage or duration of supplementation isn’t detailed in the summary, the trial’s design implies controlled intervention during pregnancy, aligning with growing interest in early-life nutritional influences on brain development. These findings emerge amid broader research into prenatal and early childhood interventions that may shape long-term cognitive health, including studies on choline’s role in neural tube formation and synaptic plasticity.

The background for this research includes prior work linking maternal nutrition to offspring neurodevelopment, such as earlier studies showing choline’s importance in fetal brain growth. The current trial builds on that foundation by testing a specific form—phosphatidylcholine—rather than general choline intake. Researchers involved likely include obstetricians, pediatric neurologists, and nutritional scientists, with the goal of identifying safe, accessible interventions to improve child outcomes. The study’s focus on social withdrawal is notable, as it may reflect broader efforts to address early